KalVista Pharmaceuticals, Inc. (KALV)
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Cambridge, MA.
Address
55 CAMBRIDGE PARKWAY
CAMBRIDGE, MA 02142
Founded
2004
Number of Employees
150
Website
http://www.kalvista.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)